Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke
- 1 December 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (12), 2922-2929
- https://doi.org/10.1161/01.str.0000099124.84425.bb
Abstract
Background and Purpose— High levels of C-reactive protein (CRP) are associated with an increased risk of future cardiovascular events in ischemic stroke. It has been hypothesized that the benefit o...Keywords
This publication has 21 references indexed in Scilit:
- Long-Term Effects of Inflammation-Sensitive Plasma Proteins and Systolic Blood Pressure on Incidence of StrokeStroke, 2002
- Chronology Versus BiologyHypertension, 2002
- Inflammation, Hemostatic Markers, and Antithrombotic Agents in Relation to Long-Term Risk of New Cardiovascular Events in First-Ever Ischemic Stroke PatientsStroke, 2002
- Is C-reactive protein an independent risk factor for essential hypertension?Journal Of Hypertension, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control StudyAmerican Journal of Epidemiology, 1996
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- The Canadian Neurological ScaleNeurology, 1989